Cytolution

Cytolution is a South Korean biotechnology company specializing in the development of next-generation exosome-based therapeutics and diagnostics. The company utilizes its proprietary Exo-Solution platform, which enables the high-purity isolation and precise engineering of extracellular vesicles to deliver diverse therapeutic cargoes, including RNA and small molecules. Cytolution's current pipeline focuses on high-unmet-need areas such as inflammatory skin diseases, regenerative medicine for hair loss, and targeted oncology. By leveraging the natural biocompatibility and targeting capabilities of exosomes, the company aims to overcome the delivery limitations of traditional biologics. Cytolution is actively advancing multiple programs through pre-clinical development while establishing strategic partnerships for global commercialization.